Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes

Nature Communications

Volumn 7, Issue , 2016, Pages

  Imamura, Minako ^a   Takahashi, Atsushi ^a,b   Yamauchi, Toshimasa ^c   Hara, Kazuo ^c,d   Yasuda, Kazuki ^e   Grarup, Niels ^f   Zhao, Wei ^g   Wang, Xu ^h   Huerta Chagoya, Alicia ⁱ   Hu, Cheng ^j   Moon, Sanghoon ^k   Long, Jirong ^l   Kwak, Soo Heon ^m   Rasheed, Asif ⁿ   Saxena, Richa ^o   Ma, Ronald C W ^p   Okada, Yukinori ^a,q   Iwata, Minoru ^r   Hosoe, Jun ^c   Shojima, Nobuhiro ^c   Iwasaki, Minaka ^c   Fujita, Hayato ^c   Suzuki, Ken ^c   Danesh, John ^s,t   Jørgensen, Torben ^u,v,w   Jørgensen, Marit E ^x   Witte, Daniel R ^y,z   Brandslund, Ivan ^aa,ab   Christensen, Cramer ^aa   Hansen, Torben ^f   Mercader, Josep M ^o,ac,ad   Flannick, Jason ^ac,ae   Moreno Macías, Hortensia ^af   Burtt, Noël P ^ac   Zhang, Rong ^j   Kim, Young Jin ^k   Zheng, Wei ^l   Singh, Jai Rup ^ag   Tam, Claudia H T ^p   Hirose, Hiroshi ^ah   Maegawa, Hiroshi ^ai   Ito, Chikako ^aj   Kaku, Kohei ^ak   Watada, Hirotaka ^al   Tanaka, Yasushi ^am   Tobe, Kazuyuki ^r   Kawamori, Ryuzo ^al   Kubo, Michiaki ^a   Cho, Yoon Shin ^an   Chan, Juliana C N ^p   Sanghera, Dharambir ^ao,ap   Frossard, Philippe ⁿ   Park, Kyong Soo ^m,aq   Shu, Xiao Ou ^l   Kim, Bong Jo ^k   Florez, Jose C ^o,ac,ae   Tusié Luna, Teresa ⁱ   Jia, Weiping ^j   Tai, E Shyong ^h,ar,as   Pedersen, Oluf ^f   Saleheen, Danish ^g,n   Maeda, Shiro ^a,at,au   Kadowaki, Takashi ^c   more..

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f Capital Region   (Denmark)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^j SHANGHAI JIAO TONG UNIVERSITY   (China)

^k Korea National Institute of Health   (South Korea)

^l VANDERBILT INGRAM CANCER CENTER   (United States)

^m Seoul National University Hospital   (South Korea)

ⁿ Center for Non Communicable Diseases   (Pakistan)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^q TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^r UNIVERSITY OF TOYAMA   (Japan)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^u Research Centre for Prevention and Health   (Denmark)

^v UNIVERSITY OF COPENHAGEN   (Denmark)

^w AALBORG UNIVERSITY   (Denmark)

^x STENO DIABETES CENTER   (Denmark)

^y AARHUS UNIVERSITY   (Denmark)

^z DANISH DIABETES ACADEMY   (Denmark)

^aa LILLEBAELT HOSPITAL   (Denmark)

^ab UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^ac BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^ad INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^ae HARVARD MEDICAL SCHOOL   (United States)

^af UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^ag CENTRAL UNIVERSITY OF PUNJAB   (India)

^ah KEIO UNIVERSITY   (Japan)

^ai SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^aj Kawasaki Medical School ^*  (Japan)

^ak KAWASAKI MEDICAL SCHOOL   (Japan)

^al JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^am ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^an Hallym University   (South Korea)

^ao UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^ap UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^aq Seoul National University   (South Korea)

^ar NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^as DUKE NUS MEDICAL SCHOOL   (Singapore)

^at UNIVERSITY OF THE RYUKYUS   (Japan)

^au UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES; ETHNIC GROUP; GENETIC ANALYSIS; HEALTH RISK; HERITABILITY; META-ANALYSIS;

ARTICLE; ASB3 GENE; ATP8B2 GENE; CCDC85A GENE; DMRTA1 GENE; ETHNIC GROUP; FAM60A GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INAFM2 GENE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; META ANALYSIS; MIR4686 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; JAPAN;

JAPAN;

ASB3 PROTEIN, HUMAN; DMRTA1 PROTEIN, HUMAN; DNA BINDING PROTEIN; FAM60A PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS;

EID: 84956612031     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10531     Document Type: Article

References (65)

1. McCarthy, M. I. Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363, 2339-2350 (2010).
2. Imamura, M. et al. Genetics of type 2 diabetes: the GWAS era and future perspectives. Endocr. J. 58, 723-739 (2011).
3. Unoki, H. et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098-1102 (2008).
4. Yasuda, K. et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40, 1092-1097 (2008).
5. Yamauchi, T. et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat. Genet. 42, 864-868 (2010).
6. Imamura, M. et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum. Mol. Genet 21, 3042-3049 (2012).
7. Hara, K. et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum. Mol. Genet. 23, 239-446 (2014).
8. Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579-589 (2010).
9. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116 (2010).
10. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981-990 (2012).
11. Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991-1005 (2012).
12. Mahajan, A. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234-244 (2014).
13. Kooner, J. S. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 43, 984-989 (2011).
14. Cho, Y. S. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nat. Genet. 44, 67-72 (2011).
15. The SIGMA Type 2 Diabetes Consortium. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506, 97-101 (2014).
16. Steinthorsdottir, V. et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 46, 294-298 (2014).
17. Moltke, I. et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512, 190-193 (2014).
18. Saxena, R. et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes 62, 1746-1755 (2013).
19. Stahl, E. A. et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44, 483-489 (2012).
20. Chan, J. C. N. et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301, 2129-2140 (2009).
21. Freedman, M. L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004).
22. Saxena, R. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
23. Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341 (2007).
24. Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
25. Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659-669 (2012).
26. Soranzo, N. et al. Common variants at 10 genomic loci influence hemoglobin A1 (C) levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239 (2010).
27. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 20, 376-381 (2014).
28. Eppig, J. T. et al. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 40, D881-D886 (2012).
29. Raychaudhuri, S. et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
30. Rossin, E. J. et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 7, e1001273 (2011).
31. Rouse, R. et al. Complex SIN3-HDAC1 histone deacetylase cycle-fluctuating regulator of the protein is a cell family with sequence similarity 60A gene regulation. J. Biol. Chem. 287, 32346-32353 (2012).
32. Holland, A. M. et al. Experimental control of pancreatic development and maintenance. Proc. Natl Acad. Sci. USA 99, 12236-12241 (2011).
33. Park, J. H. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118, 2316-2324 (2008).
34. Kikuchi, K. et al. Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res. 37, 4987-5000 (2009).
35. Walstar, S. et al. Regulation of insulin secretion by phospholipase C. Am. J. Physiol. 271, E409-E416 (1996).
36. Hald, J. et al. Pancreatic islet and progenitor cell surface markers with cell sorting potential. Diabetologia 55, 154-165 (2012).
37. Kikkawa, T. et al. Dmrta1 regulates proneural gene expression downstream of Pax6 in the mammalian telencephalon. Genes Cells 18, 636-649 (2013).
38. Wilson, M. E. et al. Gene expression cascades in pancreatic development. Mech. Dev. 120, 65-80 (2003).
39. O'Dell, S. D. et al. Molecules in focus Insulin-like growth factor II (IGF-II). Int. J. Biochem. Cell Biol. 30, 767-771 (1998).
40. Vázquez, P. et al. Non-neural tyrosine hydroxylase, via modulation of endocrine pancreatic precursors, is required for normal development of beta cells in the mouse pancreas. Diabetologia 57, 2339-2347 (2014).
41. Hakonarson, H. et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448, 591-594 (2007).
42. Flomer, D. E. P4 ATPases - Lipid flippases and their role in disease. Biochim. Biophys. Acta 1791, 628-635 (2009).
43. Salmela, A. L. et al. Mitosis as an anti-cancer drug target. Chromosoma 122, 431-449 (2013).
44. Haney, S. et al. RNAi screening in primary human hepatocytes of genes implicated in genome-wide association studies for roles in type 2 diabetes identifies roles for CAMK1D and CDKAL1, among others, in hepatic glucose regulation. PLoS ONE 8, e64946 (2013).
45. Rayasam, G. V. et al. Glycogen synthase kinase 3: more than a namesake. Br. J. Pharmacol. 156, 885-898 (2009).
46. Liu, Y. et al. Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia 53, 2600-2610 (2010).
47. Patel, S. et al. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Mol. Cell Biol. 28, 6314-6328 (2008).
48. Inagaki, N. et al. c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements. Proc. Natl Acad. Sci. USA 89, 1045-1049 (1992).
49. Meng, Q. H. et al. c-JUN, at the crossroad of the signaling network. Protein Cell 2, 889-898 (2011).
50. Bennett, B. L. et al. JNK: a new therapeutic target for diabetes. Curr. Opin. Pharmacol. 3, 420-425 (2003).
51. Alberti, K. G. et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539-553 (1998).
52. Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83, 445-456 (2008).
53. Li, Y. et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
54. Howie, B. et al. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
55. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
56. Jørgensen, T. et al. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99(1). Eur. J. Cardiovasc. Prev. Rehab. 10, 377-386 (2003).
57. Thuesen, B. H. et al. Cohort Profile: the Health2006 cohort, Research Centre for Prevention and Health. Int. J. Epidemiol. 43, 568-575 (2014).
58. Albrechtsen, A. et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 56, 298-310 (2013).
59. Lauritzen, T. et al. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int. J. Obes. Relat. Metab. Disord. 24, S6-S11 (2000).
60. Cristen, J. W. et al. METAL: fast and efficient meta-analysis of genome wide association scan. Bioinformatics 26, 2190-2191 (2010).
61. Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010).
62. Grundberg, E. et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
63. Schadt, E. E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
64. Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668-D672 (2006).
65. Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40, D1128-D1136 (2012).